TY - JOUR
T1 - Computer-Aided Detection for Pancreatic Cancer Diagnosis
T2 - Radiological Challenges and Future Directions
AU - on behalf of the E/MTIC Oncology Collaborative Group
AU - Ramaekers, Mark
AU - Viviers, Christiaan G. A.
AU - Janssen, Boris V.
AU - Hellström, Terese A. E.
AU - Ewals, Lotte
AU - van der Wulp, Kasper
AU - Nederend, Joost
AU - Jacobs, Igor
AU - Pluyter, Jon R.
AU - Mavroeidis, Dimitrios
AU - van der Sommen, Fons
AU - Besselink, Marc G.
AU - Luyer, Misha D. P.
N1 - Funding Information: This research was funded by an Eindhoven AI Systems Institute (EAISI) grant (RVO characteristic TKI2112P08). Publisher Copyright: © 2023 by the authors.
PY - 2023/7/1
Y1 - 2023/7/1
N2 - Radiological imaging plays a crucial role in the detection and treatment of pancreatic ductal adenocarcinoma (PDAC). However, there are several challenges associated with the use of these techniques in daily clinical practice. Determination of the presence or absence of cancer using radiological imaging is difficult and requires specific expertise, especially after neoadjuvant therapy. Early detection and characterization of tumors would potentially increase the number of patients who are eligible for curative treatment. Over the last decades, artificial intelligence (AI)-based computer-aided detection (CAD) has rapidly evolved as a means for improving the radiological detection of cancer and the assessment of the extent of disease. Although the results of AI applications seem promising, widespread adoption in clinical practice has not taken place. This narrative review provides an overview of current radiological CAD systems in pancreatic cancer, highlights challenges that are pertinent to clinical practice, and discusses potential solutions for these challenges.
AB - Radiological imaging plays a crucial role in the detection and treatment of pancreatic ductal adenocarcinoma (PDAC). However, there are several challenges associated with the use of these techniques in daily clinical practice. Determination of the presence or absence of cancer using radiological imaging is difficult and requires specific expertise, especially after neoadjuvant therapy. Early detection and characterization of tumors would potentially increase the number of patients who are eligible for curative treatment. Over the last decades, artificial intelligence (AI)-based computer-aided detection (CAD) has rapidly evolved as a means for improving the radiological detection of cancer and the assessment of the extent of disease. Although the results of AI applications seem promising, widespread adoption in clinical practice has not taken place. This narrative review provides an overview of current radiological CAD systems in pancreatic cancer, highlights challenges that are pertinent to clinical practice, and discusses potential solutions for these challenges.
KW - artificial intelligence
KW - clinical implementation
KW - computer-aided detection
KW - diagnostics
KW - pancreatic ductal adenocarcinoma
KW - radiological imaging
UR - http://www.scopus.com/inward/record.url?scp=85165153106&partnerID=8YFLogxK
U2 - https://doi.org/10.3390/jcm12134209
DO - https://doi.org/10.3390/jcm12134209
M3 - Review article
C2 - 37445243
SN - 0009-9147
VL - 12
JO - Clinical Chemistry
JF - Clinical Chemistry
IS - 13
M1 - 4209
ER -